Literature DB >> 2334088

Rheumatoid arthritis, methotrexate therapy, and Pneumocystis pneumonia.

R L Leff, J P Case.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2334088     DOI： 10.7326/0003-4819-112-9-716_1

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

Review 1.  The immunology of parasite infections in immunocompromised hosts.

Authors:  T Evering; L M Weiss
Journal:  Parasite Immunol       Date:  2006-11       Impact factor: 2.280

Review 2.  Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent?

Authors:  S Tariq; S M Tariq
Journal:  Postgrad Med J       Date:  1993-10       Impact factor: 2.401

Review 3.  Methotrexate-related pulmonary complications in rheumatoid arthritis.

Authors:  P Barrera; R F Laan; P L van Riel; P N Dekhuijzen; A M Boerbooms; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1994-07       Impact factor: 19.103

Review 4.  Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis.

Authors:  A Wollner; J Mohle-Boetani; R E Lambert; J L Perruquet; T A Raffin; J L McGuire
Journal:  Thorax       Date:  1991-03       Impact factor: 9.139

5.  Factors Associated with Pneumocystis jirovecii Pneumonia in Patients with Rheumatoid Arthritis Receiving Methotrexate: A Single-center Retrospective Study.

Authors:  Shin-Ichiro Ohmura; Yoichiro Homma; Takayuki Masui; Toshiaki Miyamoto
Journal:  Intern Med       Date:  2021-09-11       Impact factor: 1.282

6.  Pneumocystis carinii pneumonia as a complication of methotrexate treatment of asthma.

Authors:  L M Kuitert; A C Harrison
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

7.  Pneumocystis carinii pneumonia in HIV negative patients with primary brain tumors.

Authors:  Anuj K Mahindra; Stuart A Grossman
Journal:  J Neurooncol       Date:  2003-07       Impact factor: 4.506
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.